INDRAMEDCO Intraday Analysis...

INDRAMEDCO Share Price

Open 46.25 Change Price %
High 46.60 1 Day -1.45 -3.14
Low 43.50 1 Week -2.95 -6.18
Close 44.75 1 Month -5.05 -10.14
Volume 122774 1 Year -11.20 -20.02
52 Week High 68.50
52 Week Low 43.50
INDRAMEDCO Important Levels
Resistance 2 47.62
Resistance 1 46.44
Pivot 44.95
Support 1 43.06
Support 2 41.88
NSE INDIA Most Active Stocks
RCOM 13.35 -12.75%
JPASSOCIAT 14.20 -18.62%
ASHOKLEY 134.30 -9.50%
PNB 78.15 4.55%
RNAVAL 14.40 -6.49%
ICICIBANK 289.30 1.12%
SUZLON 8.70 -1.69%
GMRINFRA 17.00 -2.02%
SBIN 244.45 2.34%
STAR 341.00 -11.90%
More..
NSE INDIA Top Gainers Stocks
GREENFIRE 0.15 50.00%
UVSL 0.20 33.33%
DWARKESH 23.45 12.20%
SFL 1451.00 11.66%
SFL 1451.00 11.66%
SFL 1451.00 11.66%
REPRO 676.65 9.16%
DHAMPURSUG 93.05 8.89%
UTTAMSUGAR 86.00 8.04%
INDSWFTLAB 66.05 7.22%
More..
NSE INDIA Top Losers Stocks
NAKODA 0.15 -25.00%
KITEX 182.20 -19.36%
JPASSOCIAT 14.20 -18.62%
GMBREW 855.35 -16.73%
SPYL 0.25 -16.67%
MVL 0.25 -16.67%
MVL 0.25 -16.67%
SHIVATEX 387.80 -15.59%
IMFA 368.20 -14.54%
NACLIND 31.00 -14.48%
More..

Indraprastha Medical Corporation Limited (NSE: INDRAMEDCO)

INDRAMEDCO Technical Analysis 5
As on 21st May 2018 INDRAMEDCO Share Price closed @ 44.75 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 53.13 & Strong Sell for SHORT-TERM with Stoploss of 49.32 we also expect STOCK to react on Following IMPORTANT LEVELS.
INDRAMEDCO Target for May
1st Target up-side 51.25
2nd Target up-side 52.3
3rd Target up-side 53.35
1st Target down-side 48.25
2nd Target down-side 47.2
3rd Target down-side 46.15
INDRAMEDCO Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is 21.71 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 47.75
10 Day Avg Volume Traded 81.83 % More then 10 Day Average Volume
INDRAMEDCO Other Details
Segment EQ
Market Capital 1540801536.00
Sector Healthcare
Industry Hospitals
Offical website http://www.apollohospdelhi.com
INDRAMEDCO Address
INDRAMEDCO
Sarita Vihar
Delhi Mathura Road
New Delhi, 110076
India
Phone: 91 11 2692 5858
Fax: 91 11 2682 5563
INDRAMEDCO Latest News
M Ravindran appointed as Chairman of Indraprastha Gas Limited   Jagran Josh   - 10th Feb 15
Financial Results & Limited Review for Dec 31, 2014 (Standalone)   Hindu Business Line   - 29th Jan 15
Congress manifesto for the Delhi Assembly election   The Hindu   - 24th Jan 15
Change in Directorship   Hindu Business Line   - 06th Jan 15
Indraprastha Medical Corp's director MM Kutty resigns   Moneycontrol.com   - 06th Jan 15
Indraprastha Medical Corporation appoints DM Spolia as Chief Secretary   Moneycontrol.com   - 07th Nov 14
ICRA ratings for Indian debt instruments-Sep 22   Reuters   - 22nd Sep 14
Buy Indraprastha Medical; tgt of Rs 51: Firstcall Research   Moneycontrol.com   - 28th May 14
Indraprastha Medical Corporation Limited   Moneycontrol.com   - 28th Jan 14
Indraprastha Medical Corporation appoints SN Sahai as principle secretary   Moneycontrol.com   - 12th Dec 12
Interactive Technical Analysis Chart Indraprastha Medical Corporation Limited ( INDRAMEDCO NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Indraprastha Medical Corporation Limited
INDRAMEDCO Business Profile
Indraprastha Medical Corporation (Indraprastha) is a Delhi-based healthcare company which operates through Indraprastha Apollo Hospital. Indraprastha Apollo, a 695 bed specialty hospital, was commissioned Dec. 1995 in collaboration with New Delhi administration. The hospital spread across an area of 675,000 sq ft is the largest corporate hospital in India and the fourth largest in the world. The hospital has various centers such as Apollo cardiac center, Apollo cancer center, Apollo surgical science center among others. The hospital undertakes activities like health check-ups, transplants, cardiac and other surgeries. The company has operated on around 7.4 million patients. The group also owns 12 hospitals and four clinics. The company posted a sales growth of 17.8% at Rs 584.32 million for quarter ended Sep. 2006, as against Rs 496.07 million for the previous quarter ended September 2005. Net profit increased 3.52% at Rs 17.06 million as against Rs 16.48 million. The company`s net profit for the year ended Mar. 2006 stood at Rs 166.61 million while EPS stood at Rs 1.82. The current market capitalization stands at Rs 327.27 crore. The company has reported a standalone sales of Rs 177.25 crore and a Net Profit of Rs 10.89 crore for the quarter ended September 2013. The company management includes D M Spolia - Chairman, Prathap C Reddy - Vice Chairman, Jaideep Gupta - Managing Director, B Venkataraman - Director, Deepak Vaidya - Director, Ranjit Roy Chaudhury - Director, Renu S Karnad - Director, S C L Das - Director, Satnam Arora - Director, S Regunathan - Director, Shobana Kamineni - Director, Suneeta Reddy - Director, T S Narayanasami - Director, Vijay Lall - Director, V N Rajasekharan Pillai - Director, Archana Arora - Additional Director. The Registered office is at Sarita Vihar, Delhi-Mathura Road, New Delhi, Delhi - 110076.